SONOMA PHARMACEUTICALS, INC.: cost of revenue
Cost of revenue for SONOMA PHARMACEUTICALS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All SONOMA PHARMACEUTICALS, INC. financial histories
What this measure means
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
Exact concept: us-gaap:CostOfRevenue. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2016-04-01 to 2026-03-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-04-01 | 2026-03-31 | 12,114,000 | USD | 2026-06-16 | 10-K · 0001683168-26-004871 |
| 2024-04-01 | 2025-03-31 | 8,823,000 | USD | 2026-06-16 | 10-K · 0001683168-26-004871 |
| 2018-04-01 | 2019-03-31 | 10,090,000 | USD | 2019-07-01 | 10-K · 0001683168-19-002069 |
| 2017-04-01 | 2018-03-31 | 9,348,000 | USD | 2019-07-01 | 10-K · 0001683168-19-002069 |
| 2016-04-01 | 2017-03-31 | 7,157,000 | USD | 2018-06-26 | 10-K · 0001683168-18-001786 |
Related financial histories
- SONOMA PHARMACEUTICALS, INC.: total assets
- SONOMA PHARMACEUTICALS, INC.: total liabilities
- SONOMA PHARMACEUTICALS, INC.: stockholders equity
- SONOMA PHARMACEUTICALS, INC.: cash and cash equivalents
- SONOMA PHARMACEUTICALS, INC.: net income or loss
- SONOMA PHARMACEUTICALS, INC.: operating cash flow
- SONOMA PHARMACEUTICALS, INC.: capital expenditure payments
- SONOMA PHARMACEUTICALS, INC.: revenue
- SONOMA PHARMACEUTICALS, INC.: contract revenue excluding tax
- SONOMA PHARMACEUTICALS, INC.: financing cash flow
- SONOMA PHARMACEUTICALS, INC.: investing cash flow
- SONOMA PHARMACEUTICALS, INC.: retained earnings or deficit
- SONOMA PHARMACEUTICALS, INC.: basic weighted-average shares
- SONOMA PHARMACEUTICALS, INC.: diluted weighted-average shares
- SONOMA PHARMACEUTICALS, INC.: basic earnings per share
- SONOMA PHARMACEUTICALS, INC.: diluted earnings per share
- SONOMA PHARMACEUTICALS, INC.: income tax expense or benefit
- SONOMA PHARMACEUTICALS, INC.: net property, plant and equipment
- SONOMA PHARMACEUTICALS, INC.: share-based compensation expense
- SONOMA PHARMACEUTICALS, INC.: operating income or loss
- SONOMA PHARMACEUTICALS, INC.: current assets
- SONOMA PHARMACEUTICALS, INC.: interest expense
- SONOMA PHARMACEUTICALS, INC.: current liabilities
- SONOMA PHARMACEUTICALS, INC.: current accounts payable
- SONOMA PHARMACEUTICALS, INC.: net current accounts receivable
- SONOMA PHARMACEUTICALS, INC.: operating expenses
- SONOMA PHARMACEUTICALS, INC.: net inventory
- SONOMA PHARMACEUTICALS, INC.: gross profit
- SONOMA PHARMACEUTICALS, INC.: selling, general and administrative expense
- SONOMA PHARMACEUTICALS, INC.: research and development expense
Inspect the source
- Entity
- SONOMA PHARMACEUTICALS, INC. / CIK 0001367083
- Captured
- 2026-09-20T07:56:37.414Z
- SEC response SHA-256
ba342c58a8f605b240c695aa547c24b5a5b61a01177b72c6b7513a9947efc3b8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001367083.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))